252 related articles for article (PubMed ID: 33511049)
21. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F; Pappas SC; Curry MP; Reddy KR; Rubin RA; Porayko MK; Gonzalez SA; Mumtaz K; Lim N; Simonetto DA; Sharma P; Sanyal AJ; Mayo MJ; Frederick RT; Escalante S; Jamil K;
N Engl J Med; 2021 Mar; 384(9):818-828. PubMed ID: 33657294
[TBL] [Abstract][Full Text] [Related]
22. Long-term albumin infusion in decompensated cirrhosis: A review of current literature.
Wong YJ; Kumar R; Chua YJJ; Ang TL
World J Hepatol; 2021 Apr; 13(4):421-432. PubMed ID: 33959225
[TBL] [Abstract][Full Text] [Related]
23. Prevention of First Decompensation in Advanced Chronic Liver Disease.
Mandorfer M; Simbrunner B
Clin Liver Dis; 2021 May; 25(2):291-310. PubMed ID: 33838851
[TBL] [Abstract][Full Text] [Related]
24. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.
Heyens LJM; Busschots D; Koek GH; Robaeys G; Francque S
Front Med (Lausanne); 2021; 8():615978. PubMed ID: 33937277
[TBL] [Abstract][Full Text] [Related]
25. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
Flamm SL; Brown K; Wadei HM; Brown RS; Kugelmas M; Samaniego-Picota M; Burra P; Poordad F; Saab S
Liver Transpl; 2021 Aug; 27(8):1191-1202. PubMed ID: 33848394
[TBL] [Abstract][Full Text] [Related]
26. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis.
Juanola A; Solé C; Toapanta D; Ginès P; Solà E
Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860
[TBL] [Abstract][Full Text] [Related]
27. Acute Decompensation and Acute-on-Chronic Liver Failure.
Ferstl P; Trebicka J
Clin Liver Dis; 2021 May; 25(2):419-430. PubMed ID: 33838858
[TBL] [Abstract][Full Text] [Related]
28. Tunnelled peritoneal drainage catheter placement for the palliative management of refractory ascites in patients with liver cirrhosis.
Corrigan M; Thomas R; McDonagh J; Speakman J; Abbas N; Bardell S; Thompson F; Holt A; Jones R; Willis A; Karkhanis S; Rajoriya N
Frontline Gastroenterol; 2021; 12(2):108-112. PubMed ID: 33613941
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in the understanding and management of hepatorenal syndrome.
Simbrunner B; Trauner M; Reiberger T; Mandorfer M
Fac Rev; 2021; 10():48. PubMed ID: 34131658
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China.
Song J; Jin C; Shan Z; Teng W; Li J
J Transl Int Med; 2022 Jun; 10(2):134-145. PubMed ID: 35959454
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
Yoshiji H; Nagoshi S; Akahane T; Asaoka Y; Ueno Y; Ogawa K; Kawaguchi T; Kurosaki M; Sakaida I; Shimizu M; Taniai M; Terai S; Nishikawa H; Hiasa Y; Hidaka H; Miwa H; Chayama K; Enomoto N; Shimosegawa T; Takehara T; Koike K
J Gastroenterol; 2021 Jul; 56(7):593-619. PubMed ID: 34231046
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in the Management of Acute Variceal Hemorrhage.
Zanetto A; Shalaby S; Feltracco P; Gambato M; Germani G; Russo FP; Burra P; Senzolo M
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501265
[TBL] [Abstract][Full Text] [Related]
33. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.
Iwakiri Y; Trebicka J
JHEP Rep; 2021 Aug; 3(4):100316. PubMed ID: 34337369
[TBL] [Abstract][Full Text] [Related]
34. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.
Boike JR; Thornburg BG; Asrani SK; Fallon MB; Fortune BE; Izzy MJ; Verna EC; Abraldes JG; Allegretti AS; Bajaj JS; Biggins SW; Darcy MD; Farr MA; Farsad K; Garcia-Tsao G; Hall SA; Jadlowiec CC; Krowka MJ; Laberge J; Lee EW; Mulligan DC; Nadim MK; Northup PG; Salem R; Shatzel JJ; Shaw CJ; Simonetto DA; Susman J; Kolli KP; VanWagner LB;
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1636-1662.e36. PubMed ID: 34274511
[TBL] [Abstract][Full Text] [Related]
35. Management of the major complications of cirrhosis: Beyond guidelines.
Garcia-Pagan JC; Francoz C; Montagnese S; Senzolo M; Mookerjee RP
J Hepatol; 2021 Jul; 75 Suppl 1():S135-S146. PubMed ID: 34039484
[TBL] [Abstract][Full Text] [Related]
36. Clinical study on the relationship between liver cirrhosis, ascites, and hyponatremia.
Li XJ; Meng HH
World J Gastrointest Surg; 2024 Mar; 16(3):751-758. PubMed ID: 38577083
[TBL] [Abstract][Full Text] [Related]
37. Human Amniotic MSC Response in LPS-Stimulated Ascites from Patients with Cirrhosis: FOXO1 Gene and Th17 Activation in Enhanced Antibacterial Activation.
Pampalone M; Cuscino N; Iannolo G; Amico G; Ricordi C; Vitale G; Carcione C; Castelbuono S; Scilabra SD; Coronnello C; Gruttadauria S; Pietrosi G
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474048
[TBL] [Abstract][Full Text] [Related]
38. Shizao decoction for cirrhotic ascites: assessing potential targets based on network analysis combined with pharmacokinetics and metabolomics.
Li W; Hou Y; Wang Y; Liu R; Zhang H; Luo Y; Li Q; Njolibimi M; Hong B; Xu T
Front Pharmacol; 2024; 15():1298818. PubMed ID: 38323084
[No Abstract] [Full Text] [Related]
39. Focal Liver Lesions other than Hepatocellular Carcinoma in Cirrhosis: Diagnostic Challenges.
Möller K; Safai Zadeh E; Görg C; Dong Y; Cui X; Lim A; de Molo C; Serra C; Martín Algíbez A; Berzigotti A; Piscaglia F; Faiss S; Dietrich CF
J Transl Int Med; 2022 Dec; 10(4):308-327. PubMed ID: 36860624
[TBL] [Abstract][Full Text] [Related]
40. Advancements of molecular imaging and radiomics in pancreatic carcinoma.
Pang XX; Xie L; Yao WJ; Liu XX; Pan B; Chen N
World J Radiol; 2023 Jan; 15(1):10-19. PubMed ID: 36721672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
